1
|
Behnam M, Motamedzadeh A, Aalinezhad M, Dadgostar E, Rashidi Noshabad FZ, Pourfridoni M, Raei M, Mirzaei H, Aschner M, Tamtaji OR. The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy. Mol Biol Rep 2022; 49:10609-10615. [PMID: 35715607 DOI: 10.1007/s11033-022-07656-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2022] [Revised: 05/25/2022] [Accepted: 05/27/2022] [Indexed: 11/24/2022]
Abstract
Primary brain tumors are a heterogeneous group of tumors that arise from cells intrinsic to the central nervous system (CNS). Aquaporin-4 (AQP4) has been implicated in the pathogenesis of brain tumors. Previous reports have documented a relationship between AQP4 and several molecular pathways associated with the etiology of brain tumors, such as apoptosis, invasion and cell migration. AQP4 affects apoptosis via cytochrome C, Bad and Bcl-2, as well as invasion and migration via IDO1/TDO-Kyn-AhR axis, lncRNA LINC00461, miR-216a, miRNA-320a and MMPs. In addition, inhibition of AQP4 mitigates the progression of brain tumors. This review summarizes current knowledge and evidence regarding the relationship between AQP4 and brain tumors, and the mechanisms involved.
Collapse
Affiliation(s)
- Mohammad Behnam
- Student Research Committee, Kashan University of Medical Sciences, Kashan, I.R. of Iran
| | - Alireza Motamedzadeh
- Department of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, I.R. of Iran
| | - Marzieh Aalinezhad
- Department of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, I.R. of Iran
| | - Ehsan Dadgostar
- Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, I.R. of Iran.,Student Research Committee, Isfahan University of Medical Sciences, Isfahan, I.R. of Iran
| | | | - Mohammad Pourfridoni
- Student Research Committee, Jiroft University of Medical Sciences, Jiroft, I.R. of Iran
| | - Maedeh Raei
- Faculty of Medicine, Sari Branch, Islamic Azad University, Sari, I.R. of Iran
| | - Hamed Mirzaei
- Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R. of Iran.
| | - Michael Aschner
- Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461, Bronx, NY, USA
| | - Omid Reza Tamtaji
- Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, I.R. of Iran. .,Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, I.R. of Iran.
| |
Collapse
|
2
|
Nassar A, Smolanka V, Smolanka A, Chaulagain D, Devinyak O. Sphenoid wing meningiomas: peritumoral brain edema as a prognostic factor in surgical outcome. Neurosurg Rev 2022; 45:2951-2959. [PMID: 35624342 DOI: 10.1007/s10143-022-01816-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 05/03/2022] [Accepted: 05/17/2022] [Indexed: 11/29/2022]
Abstract
Sphenoidal meningiomas constitute 18% of intracranial masses, and still present a difficult surgical challenge. PTBE has been associated with several complications and future recurrence. This study aims to evaluate the outcome of the operatively treated sphenoid wing meningiomas in relation to PTBE as a prognostic factor in a series of 65 patients. The clinical materials of 65 patients with SWM treated microsurgically between 2007 and 2020 were analyzed retrospectively. Follow-up ranged from 6 to 156 months (median, 86). Clinical outcomes include postoperative major neurological deficit, quality of life using KPS, recurrence, and mortality rates. The mean age of patients was 53.9 years (range 20-74), males 24.6% and females75.4%. An edema index (EI) of 1 (40%) was considered as absent edema, and EI > 1 (60%) indicated present edema. Total resection (Simpson I-II) was achieved in 64.6% and subtotal (Simpson IV) in 13.8%. Postoperative complications included vision impairment in 3 patients, motor weakness 6, third nerve palsy 6, intraoperative bleeding and edema 5, and MCA infarct 2, recurrence in 17% and 7.7% died. In univariate analysis, we found that the PTBE is one of the serious risk factors in the immediate surgical outcomes and complication, though more data is needed to support this claim, while having a negative effect on postoperative KPS at short-term follow up (χ2 = 6.44, p = 0.011). PTBE was associated with decline in KPS and quality of life in the early postoperative period (three months) while showing no significant effect at long-term outcomes.
Collapse
Affiliation(s)
- Abdalrahman Nassar
- Uzhhorod Regional Center of Neurosurgery and Neurology, Uzhhorod National University, Uzhhorod, Ukraine.
| | - Volodymyr Smolanka
- Uzhhorod Regional Center of Neurosurgery and Neurology, Uzhhorod National University, Uzhhorod, Ukraine
| | - Andriy Smolanka
- Uzhhorod Regional Center of Neurosurgery and Neurology, Uzhhorod National University, Uzhhorod, Ukraine
| | - Dipak Chaulagain
- Uzhhorod Regional Center of Neurosurgery and Neurology, Uzhhorod National University, Uzhhorod, Ukraine
| | - Oleg Devinyak
- Department of Pharmacy, Uzhhorod National University, Uzhhorod, Ukraine
| |
Collapse
|
3
|
Bečulić H, Skomorac R, Jusić A, Alić F, Mašović A, Burazerović E, Omerhodžić I, Dorić M, Imamović M, Mekić-Abazović A, Efendić A, Udovčić-Gagula D. CORRELATION OF PERITUMORAL BRAIN EDEMA WITH MORPHOLOGICAL CHARACTERISTICS AND KI67 PROLIFERATIVE INDEX IN RESECTED INTRACRANIAL MENINGIOMAS. Acta Clin Croat 2019; 58:42-49. [PMID: 31363324 PMCID: PMC6629213 DOI: 10.20471/acc.2019.58.01.06] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
The aim of the study was to analyze correlation between morphological characteristics of intracranial meningiomas and Ki67 labeling index (Ki67 LI), and their influence on peritumoral brain edema (PTBE). There were 41 consecutive patients with intracranial meningiomas surgically treated at the Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina, during the period from January 2010 to December 2015. We reviewed clinical data including patient age, gender, magnetic resonance imaging (MRI) characteristics of the tumor and peritumoral edema, tumor margins, intraoperative characteristics, histopathologic grade and Ki67 LI. In all cases, follow up MRI was obtained at about three months after resection and PTBE was analyzed. Our research showed the tumor volume, tumor margins, and intraoperative signs of arachnoidal and pial invasion to be associated with PTBE in intracranial meningiomas. Ki67 LI expression correlated with PTBE. This study showed the resolution of PTBE to depend on invasive behavior of meningioma and KI67 LI. PTBE, pial/cortical and arachnoidal invasion significantly influence the extent of surgical resection.
Collapse
Affiliation(s)
| | - Rasim Skomorac
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Aldin Jusić
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Fahrudin Alić
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Anes Mašović
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Eldin Burazerović
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Ibrahim Omerhodžić
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Mirsad Dorić
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Melica Imamović
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Alma Mekić-Abazović
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Alma Efendić
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| | - Dalma Udovčić-Gagula
- 1Department of Neurosurgery, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 2Department of Neurosurgery, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina; 3Institute of Pathology, Medical Faculty of Sarajevo, Sarajevo, Bosnia and Herzegovina; 4Department of Emergency Medicine, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 5Department of Oncology and Radiotherapy, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 6Department of Radiology, Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina; 7Institute of Pathology, Sarajevo University Hospital Centre, Sarajevo, Bosnia and Herzegovina
| |
Collapse
|
6
|
Ildan F, Erman T, Göçer AI, Tuna M, Bağdatoğlu H, Cetinalp E, Burgut R. Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up. Skull Base 2011; 17:157-71. [PMID: 17973029 DOI: 10.1055/s-2007-970554] [Citation(s) in RCA: 77] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
We reviewed the clinical, radiological, surgical, and histopathological features of patients with meningiomas to identify factors that can predict tumor recurrence after "microscopic total removal," to improve preoperative surgical planning, and to help determine the need for close radiological observation at shorter intervals or the need for radiotherapy as an adjuvant treatment in the early postoperative period. Clinical data, magnetic resonance imaging studies, angiographic data, operative reports, and histopathological findings were examined retrospectively in 137 patients with a meningioma treated microsurgically and with no evidence of residual tumor on postoperative MR images. Based on univariate analysis, tumor size, a mushroom shape, proximity to major sinuses, edema, osteolysis, cortical penetration, signal intensity on T2-weighted MRIs, pial-cortical arterial supply, presence of a brain-tumor interface in surgery, Simpson's criteria, and histopathological classification were significant predictors for recurrence. However, age, gender, location of tumor, dural tail, calcification, signal intensity on T1-weighted images, and histopathologic subtypes in the benign group were not significant predictors. By Cox regression analysis the most important variables related to the time to recurrence were mushroom shape, osteolysis, dural tail, and proximity to major sinuses. Aggressive surgical therapy with wider dural removal should be considered in the presence of the preoperative predictors of a recurrence. Close radiological observation at shorter intervals or radiotherapy should be considered as adjuvant therapy in high-risk patients based on surgical findings predicting recurrence related to the brain-tumor interface, Simpson's criteria, and histopathological findings in the early postoperative period.
Collapse
Affiliation(s)
- Faruk Ildan
- Department of Neurosurgery, Cukurova University, School of Medicine, Adana, Turkey
| | | | | | | | | | | | | |
Collapse
|